Skip to Main Content

Key Features

Essentials of Diagnosis

  • Distinction in acute coronary syndrome (ACS) between patients with and without ST-segment elevation at presentation is essential to determine need for reperfusion therapy

  • Fibrinolytic therapy is harmful in ACS without ST-segment elevation, unlike with ST-segment elevation where acute reperfusion saves lives

  • Antiplatelet and anticoagulation therapies and coronary intervention are mainstays of treatment

General Considerations

  • Acute coronary syndromes comprise the spectrum of unstable cardiac ischemia from unstable angina to myocardial infarction (MI)

  • Acute coronary syndromes are classified based on the presenting ECG as either "ST-segment elevation" (STEMI) or "non–ST-segment elevation"

  • The evolution of cardiac biomarkers allows determination of whether MI has occurred

  • The universal definition of myocardial infarction is a rise of cardiac biomarkers with at least one value above the 99th percentile of the upper reference limit together with evidence of myocardial ischemia with at least one of the following:

    • Symptoms of ischemia

    • ECG changes of new ischemia

    • New Q waves

    • Imaging evidence of new loss of viable myocardium or new wall motion abnormality

  • Acute coronary syndromes represent a dynamic state in which patients frequently shift from one category to another, as new ST elevation can develop after presentation and cardiac biomarkers can become abnormal with recurrent ischemic episodes

Clinical Findings

Symptoms and Signs

  • Angina occurs at rest or with minimal exertion

  • Substernal chest pain or discomfort that may radiate to the jaw, left shoulder, or arm

  • Dyspnea, nausea, diaphoresis or syncope may either accompany the chest discomfort or may be the only symptom of ACS

  • About one-third of patients with MI have no chest pain per se—these patients tend to be older, female, have diabetes, and be at higher risk for subsequent mortality

  • Patients with ACS have signs of heart failure in about 10% of cases, and this is also associated with higher risk of death

Differential Diagnosis

  • MI with ST-segment elevation

  • Aortic dissection

  • Pulmonary embolism

  • Tension pneumothorax

  • Pericarditis

  • Esophageal rupture

  • Stress cardiomyopathy (Tako-Tsubo cardiomyopathy or apical ballooning syndrome)

Diagnosis

Laboratory Tests

  • Depending on the time from symptom onset to presentation, initial laboratory findings may be normal

  • Cardiac myocyte necrosis, myoglobin, creatine kinase (CK)-MB, and troponin I and T may all be used to identify acute MI

    • In patients with STEMI, these initial markers are often within normal limits as the patient is being rushed to immediate reperfusion

    • In patients without ST-segment elevation, it is the presence of abnormal CK-MB or troponin values that are associated with myocyte necrosis and the diagnosis of MI

  • Serum creatinine is an important determinant of risk

  • Estimated creatinine clearance is important to guide dosing of certain antithrombotics, including eptifibatide and enoxaparin

Diagnostic Studies

  • ECG changes

    • ST-segment elevation, ST-segment depression, or T wave flattening or ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.